Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ecopipam (1 trial)
Childhood-Onset Fluency Disorder (Phase 3)
Communication Disorders (Phase 3)
Disease (Phase 3)
Language Disorders (Phase 3)
Speech Disorders (Phase 3)
Stuttering (Phase 3)
Trials (1 total)
Trial APIs (1 total)